Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.
Nontypeable (NT) Haemophilus influenzae is an important cause of otitis media in children. We have shown previously that NT H. influenzae mutants defective in their ability to sialylate lipopolysaccharide (LPS), called siaB mutants, show attenuated virulence in a chinchilla model of experimental otitis media (EOM). We show that complement is a key arm of host innate immunity against NT H. influenzae-induced EOM. Depleting complement in chinchillas by use of cobra venom factor (CoVF) rendered two otherwise avirulent siaB mutants fully virulent and able to cause EOM with severity similar to that of wild-type strains. Clearance of infection caused by siaB mutants in CoVF-treated animals coincided with reappearance of C3. Wild-type strains were more resistant to direct complement-mediated killing than their siaB mutants. The serum-resistant strain bound less C3 and C4 than the serum-sensitive strain. Neither NT H. influenzae strain tested bound factor H (alternative complement pathway regulator). Selective activation of the alternative pathway resulted in more C3 binding to siaB mutants. LPS sialylation had a more profound impact on the amount of alternative-pathway-mediated C3 binding ( approximately 5-fold decrease in fluorescence) when LPS was the main C3 target, as occurred on the more serum-resistant strain. In contrast, only an approximately 1.5-fold decrease in fluorescence intensity of C3 binding was seen with the serum-sensitive strain, where surface proteins predominantly bound C3. Differences in binding sites for C3 and C4 may account for variations in serum resistance between NT H. influenzae strains, which in turn may impact their virulence. These data demonstrate a central role for complement in innate immune defenses against NT H. influenzae infections and specifically EOM.
Figueira
Marisol A
MA
Section of Pediatric Infectious Diseases, Maxwell Finland Laboratory for Infectious Diseases, Room 508, 774 Albany Street, Boston Medical Center, Boston, MA 02118, USA. maf6559@bu.edu
Ram
Sanjay
S
Goldstein
Richard
R
Hood
Derek W
DW
Moxon
E Richard
ER
Pelton
Stephen I
SI
D000818:Animals; D015153:Blotting, Western; D002682:Chinchilla; D003167:Complement Activation / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology* / Q000378:metabolism; D004195:Disease Models, Animal; D004432:Ear, Middle / Q000276:immunology*; D005434:Flow Cytometry; D019741:Haemophilus influenzae type b / Q000276:immunology* / Q000472:pathogenicity*; D008070:Lipopolysaccharides / Q000276:immunology / Q000378:metabolism; D019158:N-Acetylneuraminic Acid / Q000378:metabolism*; D010033:Otitis Media / Q000276:immunology* / Q000382:microbiology; D014774:Virulence
D008070:Lipopolysaccharides; D003165:Complement System Proteins; D019158:N-Acetylneuraminic Acid